The role of race in heart failure therapy

Clyde W. Yancy*

*Corresponding author for this work

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Heart failure in blacks is a unique malady characterized by a different natural history, more worrisome prognosis, and potential variances in the response to current medical therapy for heart failure. The overwhelming burden of hypertension as a putative cause of left ventricular dysfunction identifies this illness. Although differences in the response to medical therapy have been described, angiotensin-converting enzyme inhibitors and b-blockers remain the most appropriate therapy. Certain genetic polymorphisms may exist that explain the observed differences.

Original languageEnglish (US)
Pages (from-to)218-225
Number of pages8
JournalCurrent Cardiology Reports
Volume4
Issue number3
DOIs
StatePublished - Dec 1 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The role of race in heart failure therapy'. Together they form a unique fingerprint.

  • Cite this